$2.02
+1.0%Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
MDAI • NASDAQ
| Spectral AI, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||
-7.6M | -15.3M | -20.9M | -2.9M | -4M | |
635K | 588K | 722K | 568K | 1K | |
1.1M | 1M | 1.2M | 1.2M | 1.4M | |
-2.1M | 6.4M | 4M | -57K | -298K | |
(0.0) | (11K) | (114K) | (53K) | (255K) | |
-2M | -1.9M | 1.6M | 84K | 2K | |
-9.9M | -9.2M | -13.2M | -1.2M | -2.9M | |
INVESTING ACTIVITIES | |||||
(0.0) | (0.0) | (0.0) | (0.0) | -7K | |
(0.0) | (0.0) | (0.0) | (0.0) | -7K | |
FINANCING ACTIVITIES | |||||
13.4M | 4.1M | 3.4M | 0.0 | 14.6M | |
6.7M | 5.3M | -483K | -785K | -701K | |
0.0 | 177K | 976K | 0.0 | 4K | |
20.1M | 9.6M | 3.8M | -785K | 13.9M | |
CASH FLOW SUMMARY | |||||
37K | -9K | 12K | 0.0 | 0.0 | |
10.2M | 367K | -9.4M | -1.9M | 11M | |
5.2M | 4.8M | 14.2M | 16.1M | 5.1M | |
15.4M | 5.2M | 4.8M | 14.2M | 16.1M | |
-9.9M | -9.2M | -13.2M | -1.2M | -2.9M |
MDAI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 01, 2026 | May 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 26, 2026 | May 26, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 13, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 22, 2026 | April 17, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 16, 2026 | May 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 08, 2026 | April 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 25, 2026 | March 24, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 20, 2026 | March 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 10, 2026 | February 09, 2026 | 2026 |
Continue your MDAI research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.